Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J. 2003 Oct; 146(4):628-34.

View in: PubMed

subject areas

Angina, Unstable
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Anticoagulants
Coronary Disease
Drug Therapy, Combination
Enoxaparin
Female
Fibrinolytic Agents
Hemorrhage
Heparin, Low-Molecular-Weight
Humans
Immunoglobulin Fab Fragments
Male
Middle Aged
Myocardial Infarction
Peptides
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Syndrome
Thrombolytic Therapy
Treatment Outcome
Tyrosine

authors with profiles

Robert Harrington